医薬政策に関わる情報コンシェルジュ
Pharma Policy Planning P-Cubed
Pharma Policy Planning P-Cubed
| Status | Update | Specialty |
| Availability | Nov. 8, 2024 | Depakine Chrono 500 mg, extended-release scored film-coated tablet – [sodium valproate] |
| Supply tension | Nov. 8, 2024 | Lantus Solostar 100 units/ ml, solution for injection in pre-filled pen – [insulin glargine]. |
| Availability | Nov. 8, 2024 | Fasturtec 1.5 mg/ml, powder and solvent for solution to be diluted for infusion 1 ml glass ampoule – [rasburicase] |
| Supply tension | Nov. 8, 2024 | Sinemet 250 mg/25 mg, scored tablet – [levodopa – carbidopa] |
| Supply tension | Nov. 8, 2024 | Sinemet 100 mg/10 mg, tablet – [levodopa – carbidopa] [levodopa – carbidopa] [levodopa – carbidopa] [levodopa – carbidopa |
| Out of stock | Nov. 8, 2024 | Etoposide Accord 20 mg/ml, dilutable solution for infusion – [etoposide] |
| Supply tension | Nov. 7, 2024 | Cyanokit 5 g, powder for solution for infusion – [hydroxocobalamin] |
| Out of stock | Nov. 7, 2024 | Marsilid 50 mg, scored tablet – [iproniazide] |
| Supply tension | Nov. 7, 2024 | Vitamin B12 Gerda 1000 µg/4 ml, solution for injection (IM) and oral use – [cyanocobalamine] |
| Supply tension | Nov. 7, 2024 | Vitamin B12 Delagrange 1000 micrograms/2 ml, solution for injection (IM) and oral use – [cyanocobalamin] |
| Supply tension | Nov. 7, 2024 | Fluorouracil Teva 50 mg/ml, dilutable solution for infusion, 100 ml bottle – [fluorouracil] |
| Out of stock | Nov. 6, 2024 | Zophren 2 mg/ml, solution for injection in ampoule (IV) (box 1 ampoule of 4 ml) – [ondansetron]. |
| Supply tension | Nov. 5, 2024 | Pegasys 90 micrograms, 135 micrograms and 180 micrograms solution for injection in pre-filled syringe – [peginterferon alfa-2a]. |
| Out of stock | Nov. 5, 2024 | Potassium citrate AP-HP 1 g, sachet of 100 capsules – [potassium citrate] |
| Availability | Nov. 5, 2024 | Abacavir, Lamivudine, Zidovudine Viatris 300 mg/150 mg/300 mg, film-coated tablet – [abacavir (sulfate d’), lamivudine, zidovudine] |
| Out of stock | 5-Nov-24 | Icatibant Viatris 30 mg, solution for injection in pre-filled syringe – [icatibant (acetate) |
| Supply tension | Nov. 4, 2024 | Normal human immunoglobulin IV and SC (based on) – [Normal human immunoglobulin (IgG)]. |
| Supply tension | Nov. 4, 2024 | Concerta LP, extended-release tablet – [methylphenidate (hydrochloride) |
| Marketing discontinuation | Nov. 4, 2024 | Tsoludose, oral solution in unidose container – [levothyroxine] |
| Supply tension | Nov. 4, 2024 | Furosemide Zentiva 500 mg, scored tablet – [furosemide] |
| Supply tension | Nov. 4, 2024 | Methylphenidate Biogaran LP, extended-release tablet – [methylphenidate (hydrochloride) |
| Active ingredients | Message type | Type of reason | Date of the last message |
| Eletriptan hydrobromide | Change notification | Other | 08.11.2024 |
| Terazosin hydrochloride dihydrate | Initial notification | Other | 08.11.2024 |
| Cinacalcethydrochloride | Change notification | Other | 08.11.2024 |
| Paricalcitol | Change notification | Other | 08.11.2024 |
| Vinblastine sulfate | Change notification | Production problem | 08.11.2024 |
| Sodium thiosulphate (Ph.Eur.) | Change notification | Other | 07.11.2024 |
| Sodium thiosulphate (Ph.Eur.) | Initial notification | Other | 07.11.2024 |
| Metronidazole | Change notification | Other | 06.11.2024 |
| Fosfomycin sodium (Ph.Eur.) | Initial notification | Production problem | 06.11.2024 |
| Atenolol; chlorthalidone | Change notification | Other | 06.11.2024 |
| Insulin aspart | Change notification | Other | 06.11.2024 |
| Buprenorphine hydrochloride | Change notification | Production problem | 06.11.2024 |
| Clobetasol propionate (Ph.Eur.) | Change notification | Other | 06.11.2024 |
| Lanthanum(III) carbonate x H<2>O | Change notification | Other | 06.11.2024 |
| Haloperidol decanoate | Initial notification | Production problem | 06.11.2024 |
| Carbamazepine | Change notification | Production problem | 05.11.2024 |
| Ciprofloxacin hydrochloride (1:1) 1 H<2>O | Change notification | Production problem | 05.11.2024 |
| Phenoxymethylpenicillin potassium | Change notification | Other | 05.11.2024 |
| Carboplatin | Change notification | Other | 05.11.2024 |
| Cefadroxil monohydrate | Change notification | Other | 05.11.2024 |
| Amoxicillin trihydrate | Change notification | Other | 05.11.2024 |
| Oxcarbazepine | Change notification | Other | 05.11.2024 |
| Azithromycin dihydrate | Change notification | Other | 05.11.2024 |
| Ethosuximide | Change notification | Other | 05.11.2024 |
| Candesartancilexetil | Change notification | Other | 05.11.2024 |
| Alprostadil | Change notification | Other | 05.11.2024 |
| Levetiracetam | Initial notification | Other | 05.11.2024 |
| Oxazepam | Initial notification | Other | 05.11.2024 |
| Dexamethasone | Initial notification | Other | 05.11.2024 |
| Insulin aspart | Change notification | Other | 05.11.2024 |
| Azithromycin dihydrate | Change notification | Other | 05.11.2024 |
| Hydromorphone hydrochloride | Change notification | Other | 05.11.2024 |
| Azithromycin dihydrate | Change notification | Other | 05.11.2024 |
| Phenoxymethylpenicillin potassium | Change notification | Production problem | 05.11.2024 |
| Ciprofloxacin hydrochloride (1:1) 1 H<2>O | Change notification | Other | 05.11.2024 |
| Azithromycin dihydrate | Change notification | Other | 05.11.2024 |
| Minocycline hydrochloride ((anhydrous, not pharmacopoeia compliant)) | Change notification | Other | 05.11.2024 |
| Mesalazine | Change notification | Other | 04.11.2024 |
| Phenytoin | Initial notification | Other | 04.11.2024 |
| Timolol maleate | Change notification | Production problem | 04.11.2024 |
| Phenylephrine hydrochloride | Initial notification | Production problem | 04.11.2024 |
| Darifenacin hydrobromide | Initial notification | Other | 04.11.2024 |
| Acemetacin | Change notification | Production problem | 04.11.2024 |
| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| bupivacaine hydrochloride monohydrate | Injection, solution | 52.7 mg | Current | Unavailable | Manufacturing | 8/11/2024 |
| amlodipine besilate | Tablet, uncoated | 6.94 mg | Anticipated | Available | Manufacturing | 8/11/2024 |
| midazolam | Injection, solution | 5 mg/mL | Current | Limited Availability | Manufacturing | 8/11/2024 |
| sodium pyrophosphate | Injection, powder for | 30 mg | Current | Emergency Supply Only | Manufacturing | 8/11/2024 |
| potassium clavulanate~amoxicillin trihydrate | Suspension, powder for | 7.45 mg/mL~28.7 mg/mL | Current | Unavailable | Manufacturing | 8/11/2024 |
| benzathine benzylpenicillin tetrahydrate | Injection, suspension | 1200000 USP Unit | Anticipated | Available | Manufacturing | 8/11/2024 |
| iopromide | Injection, solution | 498.72 mg/mL | Resolved | Available | Unexpected increase in consumer demand | 8/11/2024 |
| hydrocortisone sodium succinate | Injection, powder for | 334.25 mg | Resolved | Available | Manufacturing | 8/11/2024 |
| acetylcysteine | Injection, concentrated | 2 g | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 8/11/2024 |
| diazepam | Tablet, uncoated | 2 mg | Anticipated | Available | Manufacturing | 8/11/2024 |
| risperidone | Tablet, film coated | 2 mg | Anticipated | Available | Unexpected increase in consumer demand | 8/11/2024 |
| zolmitriptan | Tablet, film coated | 2.5 mg | Current | Unavailable | Manufacturing | 8/11/2024 |
| duloxetine hydrochloride | Capsule, enteric | 33.66 mg | Current | Unavailable | Unexpected increase in consumer demand | 8/11/2024 |
| citalopram hydrobromide | Tablet, film coated | 49.98 mg | Current | Unavailable | Manufacturing | 8/11/2024 |
| meloxicam | Capsule, hard | 15 mg | Resolved | Available | Manufacturing | 8/11/2024 |
| anastrozole | Tablet, film coated | 1 mg | Current | Limited Availability | Manufacturing | 8/11/2024 |
| fluorouracil | Injection, solution | 50 mg/mL | Current | Limited Availability | Manufacturing | 8/11/2024 |
| mesalazine | Tablet, enteric coated | 250 mg | Anticipated | Available | Manufacturing | 8/11/2024 |
| benzathine benzylpenicillin tetrahydrate | Injection, suspension | 600000 USP Unit | Current | Unavailable | Manufacturing | 8/11/2024 |
| nebivolol hydrochloride | Tablet | 1.363 mg | Current | Limited Availability | Manufacturing | 8/11/2024 |
| nebivolol hydrochloride | Tablet | 5.45 mg | Current | Limited Availability | Manufacturing | 8/11/2024 |
| nebivolol hydrochloride | Tablet | 10.9 mg | Resolved | Available | Manufacturing | 8/11/2024 |
| hydrochlorothiazide~amlodipine besilate~olmesartan medoxomil | Tablet, film coated | 12.5 mg~6.95 mg~40 mg | Resolved | Available | Manufacturing | 8/11/2024 |
| tamoxifen citrate | Tablet | 30.34 mg | Current | Limited Availability | Manufacturing | 8/11/2024 |
| lurasidone hydrochloride | Tablet, film coated | 80 mg | Resolved | Available | Manufacturing | 8/11/2024 |
| lurasidone hydrochloride | Tablet, film coated | 40 mg | Resolved | Available | Manufacturing | 8/11/2024 |
| lanreotide acetate | Injection, solution | 100 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 8/11/2024 |
| lanreotide acetate | Injection, solution | 66.67 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 8/11/2024 |
| daptomycin | Inhalation, powder for | 350 mg | Current | Limited Availability | Manufacturing | 8/11/2024 |
| morphine sulfate pentahydrate | Tablet, film coated | 10 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 8/11/2024 |
| clindamycin phosphate | Cream | 22.8 mg/g | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 8/11/2024 |
| clonazepam | Tablet, uncoated | .5 mg | Current | Limited Availability | Manufacturing | 8/11/2024 |
| cabergoline | Tablet, uncoated | 2 mg | Current | Limited Availability | Manufacturing | 8/11/2024 |
| baclofen | Tablet, uncoated | 25 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 8/11/2024 |
| adrenaline (epinephrine) acid tartrate | Injection, solution | 1.82 mg/mL | Anticipated | Available | Manufacturing | 7/11/2024 |
| fluconazole | Capsule, hard | 200 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 7/11/2024 |
| olanzapine | Tablet, orally disintegrating | 20 mg | Anticipated | Available | Manufacturing | 7/11/2024 |
| dutasteride~tamsulosin hydrochloride | Capsule, modified release | 500 microgram~400 microgram | Current | Limited Availability | Manufacturing | 7/11/2024 |
| tacrolimus monohydrate | Capsule, hard | 1.022 mg | Anticipated | Available | Manufacturing | 7/11/2024 |
| bisoprolol fumarate | Tablet | 10 mg | Current | Unavailable | Manufacturing | 7/11/2024 |
| levetiracetam | Tablet, film coated | 1000 mg | Current | Unavailable | Manufacturing | 7/11/2024 |
| escitalopram oxalate | Tablet, film coated | 12.74 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 7/11/2024 |
| escitalopram oxalate | Tablet, film coated | 25.47 mg | Current | Unavailable | Manufacturing | 7/11/2024 |
| carboplatin | Injection, solution | 450 mg | Anticipated | Available | Manufacturing | 7/11/2024 |
| tadalafil | Tablet, film coated | 20 mg | Current | Limited Availability | Manufacturing | 7/11/2024 |
| simvastatin | Tablet, film coated | 20 mg | Current | Unavailable | Manufacturing | 7/11/2024 |
| noradrenaline (norepinephrine) acid tartrate monohydrate | Injection, concentrated | 8 mg | Current | Limited Availability | Manufacturing | 7/11/2024 |
| hydrochlorothiazide~irbesartan | Tablet, film coated | 12.5 mg~300 mg | Anticipated | Available | Manufacturing | 7/11/2024 |
| cerliponase alfa | Injection, solution | 30 mg/mL | Resolved | Available | Manufacturing | 7/11/2024 |
| dutasteride~tamsulosin hydrochloride | Capsule, modified release | 500 microgram~400 microgram | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 7/11/2024 |
| estradiol | Drug delivery system, transdermal | .39 mg | Current | Unavailable | Manufacturing | 7/11/2024 |
| estradiol | Drug delivery system, transdermal | 1.56 mg | Current | Unavailable | Manufacturing | 7/11/2024 |
| trimethoprim | Tablet, uncoated | 300 mg | Current | Limited Availability | Manufacturing | 7/11/2024 |
| flecainide acetate | Tablet | 50 mg | Current | Unavailable | Manufacturing | 7/11/2024 |
| cefaclor monohydrate | Oral Liquid, powder for | 52.45 mg/mL | Current | Unavailable | Unexpected increase in consumer demand | 7/11/2024 |
| potassium clavulanate~amoxicillin trihydrate | Tablet, film coated | 149 mg~574 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 7/11/2024 |
| tirzepatide | Injection, solution | 7.5 mg | Current | Unavailable | Commercial Changes / Commercial viability | 7/11/2024 |
| tirzepatide | Injection, solution | 12.5 mg | Current | Unavailable | Commercial Changes / Commercial viability | 7/11/2024 |
| tirzepatide | Injection, solution | 10 mg | Current | Unavailable | Commercial Changes / Commercial viability | 7/11/2024 |
| tirzepatide | Injection, solution | 2.5 mg | Current | Unavailable | Commercial Changes / Commercial viability | 7/11/2024 |
| nizatidine | Capsule | 300 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 7/11/2024 |
| clarithromycin | Tablet, film coated | 250 mg | Current | Limited Availability | Unexpected increase in consumer demand | 7/11/2024 |
| fluticasone furoate | Spray, suspension | 27.5 microgram | Anticipated | Available | Unexpected increase in consumer demand | 6/11/2024 |
| silver sulfadiazine | Cream | 10 mg/g | Current | Unavailable | Manufacturing | 6/11/2024 |
| mycophenolate mofetil | Tablet, film coated | 500 mg | Current | Unavailable | Manufacturing | 6/11/2024 |
| sildenafil citrate | Tablet, film coated | 28.1 mg | Current | Limited Availability | Manufacturing | 6/11/2024 |
| mycophenolate mofetil | Tablet, film coated | 500 mg | Resolved | Available | Manufacturing | 6/11/2024 |
| esomeprazole | Capsule, enteric | 40 mg | Current | Limited Availability | Manufacturing | 6/11/2024 |
| ezetimibe | Tablet, uncoated | 10 mg | Current | Unavailable | Unexpected increase in consumer demand | 6/11/2024 |
| ezetimibe | Tablet, uncoated | 10 mg | Current | Unavailable | Unexpected increase in consumer demand | 6/11/2024 |
| atomoxetine hydrochloride | Capsule, hard | 91.2 mg | Resolved | Available | Manufacturing | 6/11/2024 |
| atorvastatin calcium trihydrate | Tablet, film coated | 86.751 mg | Current | Limited Availability | Manufacturing | 6/11/2024 |
| norethisterone acetate~estradiol~estradiol | Drug delivery system, transdermal | 2.7 mg~.78 mg~.62 mg | Current | Limited Availability | Manufacturing | 6/11/2024 |
| norethisterone acetate~estradiol~estradiol | Drug delivery system, transdermal | 4.8 mg~.512 mg~.78 mg | Current | Limited Availability | Manufacturing | 6/11/2024 |
| estradiol | Drug delivery system, transdermal | .585 mg | Current | Unavailable | Manufacturing | 6/11/2024 |
| estradiol | Drug delivery system, transdermal | .78 mg | Current | Unavailable | Manufacturing | 6/11/2024 |
| estradiol | Drug delivery system, transdermal | 1.17 mg | Current | Unavailable | Manufacturing | 6/11/2024 |
| chloramphenicol | Eye Drops, solution | 5 mg/mL | Current | Unavailable | Manufacturing | 6/11/2024 |
| melatonin | Capsule, hard | 5 mg | Current | Limited Availability | Unexpected increase in consumer demand | 6/11/2024 |
| estradiol~norethisterone acetate | Drug delivery system, transdermal | .62 mg~2.7 mg | Current | Unavailable | Manufacturing | 6/11/2024 |
| norethisterone acetate~estradiol | Drug delivery system, transdermal | 4.8 mg~.512 mg | Current | Limited Availability | Manufacturing | 6/11/2024 |
| risperidone | Tablet, film coated | 4 mg | Current | Unavailable | Manufacturing | 5/11/2024 |
| oxytocin | Injection, solution | 10 IU | Current | Unavailable | Manufacturing | 5/11/2024 |
| progesterone | Pessary, compressed | 100 mg | Current | Unavailable | Manufacturing | 5/11/2024 |
| citalopram hydrobromide | Tablet, film coated | 12.495 mg | Anticipated | Available | Manufacturing | 5/11/2024 |
| citalopram hydrobromide | Tablet, film coated | 49.98 mg | Anticipated | Available | Manufacturing | 5/11/2024 |
| azithromycin dihydrate | Tablet, film coated | 524 mg | Current | Unavailable | Manufacturing | 5/11/2024 |
| hydrochlorothiazide~irbesartan | Tablet, film coated | 25 mg~300 mg | Anticipated | Available | Manufacturing | 5/11/2024 |
| tenofovir disoproxil fumarate~emtricitabine | Tablet, film coated | 300 mg~200 mg | Resolved | Available | Manufacturing | 5/11/2024 |
| tadalafil | Tablet, film coated | 10 mg | Current | Unavailable | Manufacturing | 5/11/2024 |
| tadalafil | Tablet, film coated | 20 mg | Current | Limited Availability | Manufacturing | 5/11/2024 |
| timolol maleate | Eye Drops, solution | 6.83 mg/mL | Anticipated | Available | Commercial Changes / Commercial viability | 5/11/2024 |
| levothyroxine sodium | Tablet | 50 microgram | Current | Unavailable | Manufacturing | 5/11/2024 |
| melatonin | Oral Liquid, solution | 1 mg/mL | Current | Limited Availability | Unexpected increase in consumer demand | 5/11/2024 |
| timolol maleate | Eye Drops, solution | 6.84 mg/mL | Current | Unavailable | Manufacturing | 5/11/2024 |
| gefitinib | Tablet, film coated | 250 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 5/11/2024 |
| ciprofloxacin hydrochloride | Tablet, film coated | 832.5 mg | Current | Unavailable | Manufacturing | 4/11/2024 |
| morphine hydrochloride trihydrate | Oral Liquid, solution | 2 mg/mL | Resolved | Available | Commercial Changes / Commercial viability | 4/11/2024 |
| morphine hydrochloride trihydrate | Oral Liquid, solution | 10 mg/mL | Current | Unavailable | Commercial Changes / Commercial viability | 4/11/2024 |
| metformin hydrochloride | Tablet, film coated | 1000 mg | Current | Limited Availability | Manufacturing | 4/11/2024 |
| ezetimibe | Tablet, uncoated | 10 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 4/11/2024 |
| irbesartan | Tablet, film coated | 300 mg | Current | Unavailable | Manufacturing | 4/11/2024 |
| pregabalin | Capsule, hard | 150 mg | Anticipated | Available | Manufacturing | 4/11/2024 |
| quinagolide hydrochloride | Tablet, uncoated | .0819 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 4/11/2024 |
| verapamil hydrochloride | Tablet, modified release | 180 mg | Current | Limited Availability | Manufacturing | 4/11/2024 |
| morphine sulfate pentahydrate | Capsule, modified release | 90 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 4/11/2024 |
| clonidine hydrochloride | Tablet, uncoated | 150 microgram | Current | Limited Availability | Manufacturing | 4/11/2024 |
